Monte Rosa Therapeutics Market Cap

Monte Rosa Therapeutics has a market cap or net worth of $261.65 million as of May 17, 2024. Its market cap has decreased by -9.43% in one year.

Market Cap

261.65M

Enterprise Value

109.08M

1-Year Change

-9.43%

Ranking

#3473

Market Cap Chart

Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $261.65M, a decrease of -69.05%. That is a compound annual growth rate of -33.27%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	262.70M	-0.38%
May 16, 2024	263.70M	-0.19%
May 15, 2024	264.20M	4.59%
May 14, 2024	252.60M	1.04%
May 13, 2024	250.00M	2.04%
May 10, 2024	245.00M	-6.38%
May 9, 2024	261.70M	-0.80%
May 8, 2024	263.80M	-7.41%
May 7, 2024	284.90M	-1.38%
May 6, 2024	288.90M	1.94%
May 3, 2024	283.40M	0.89%
May 2, 2024	280.90M	-5.71%
May 1, 2024	297.90M	11.66%
Apr 30, 2024	266.80M	-5.19%
Apr 29, 2024	281.40M	5.27%
Apr 26, 2024	267.30M	-2.20%
Apr 25, 2024	273.30M	-0.36%
Apr 24, 2024	274.30M	-1.30%
Apr 23, 2024	277.90M	0.76%
Apr 22, 2024	275.80M	-6.00%
Apr 19, 2024	293.40M	-1.18%
Apr 18, 2024	296.90M	2.06%
Apr 17, 2024	290.90M	-4.28%
Apr 16, 2024	303.90M	-7.77%
Apr 15, 2024	329.50M	-8.88%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AxoGen	263.32M
Rani Therapeutics Holdings	263.19M
Sanara MedTech	263.07M
Cybin	262.63M
Zura Bio	262.10M
Sera Prognostics	261.41M
Auna S.A.	260.40M
ESSA Pharma	258.19M

Market Cap Rankings